Status:
RECRUITING
Peri-implantitis Implantoplasty Treatment
Lead Sponsor:
University of Oslo
Conditions:
Peri-Implantitis
Peri-implant Mucositis
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This double arm, split-mouth, single centre, controlled, randomised clinical study is designed to examine the effect of implantoplasty in treatment of peri-implantitis. Peri-implantitis will be treat...
Eligibility Criteria
Inclusion
- Peri-implantitis (according to 2018 criteria) on minimum 2 implants of similar surface and defect type
- Competent to give consent
- Exposed, modified implant surface with loss \>2mm
Exclusion
- Previous radiotherapy to the jaws, current use of chemotherapy, systemic long-term corticosteroid treatment
- Present or past use of bisphosphonate treatment • Pregnant or nursing subjects
- Patients classified as \> class II according to ASA classification
- Implant unavailable for implantoplasty treatment
- Inhability to comprehend and respond to the quality of life questionnaire
- Examiners/operators deem original placement of implant (angle, position) suboptimal and considered to play a major role in development of peri-implantitis
- History of peri-implantitis surgery prior to 6 months of screening
Key Trial Info
Start Date :
October 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2027
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04052373
Start Date
October 15 2019
End Date
June 15 2027
Last Update
December 5 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo
Oslo, Norway, 0455
2
Institute of Clinical Dentistry, University of Oslo, Norway
Oslo, Norway